HICKSVILLE, NY, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB), is pleased to announce that Senator Ronald A. Silver has joined its Corporate Advisory Board. The purpose of the Advisory Board is to assist and advise the Board of Directors and Executive team’s effort in growing Canbiola fiscally and in a socially responsible manner and the Company welcomes a man with extensive legislative and regulatory experience.
Senator Ronald A. Silver was first elected to the Florida House of Representatives in 1978 and continued his tenure in that body until 1992. While in the Florida House Silver served in major positions including Majority Whip (1984-1986) and Majority Leader (1986-1988). He also chaired various committees including the Select Committee on Juvenile Justice, Criminal Justice, Ethics and Elections and the subcommittee of Appropriations on General Government. He was then elected to the Florida Senate in 1992 and subsequently re-elected, serving as the Majority (Democratic) leader for the 1994 session. During his last term in the Senate, he was designated by both the House and Senate as the Dean of the Legislature recognizing his standing as the longest serving member. His career as a lawmaker has yielded a vast and extensive knowledge of public policy issues and the legislative process, allowing him to be an advocate and servant for his diverse community. Throughout his tenure in the House and Senate, Mr. Silver has been known to tackle tough issues, transcend partisanship and build strong coalitions and in addition served on the Judiciary Committee, which heard all condominium issues. As Senator, he served on a variety of committees and was chairman of both the Appropriations Subcommittee on Health and Human Services and Criminal Justice. His career in the Senate has earned praise from his colleagues, in both the legislature and other branches of government throughout the nation. In 1993 Mr. Silver was elected Chairman of the Southern Legislative Conference (17 Southern States) of the Council of State Governments. Most recently, a new prescription drug plan of Medicare-eligible senior citizens in the State of Florida has been named "Silver Saver" in his honor. Since his retirement from the Senate in 2002, Mr. Silver also functions as President of his own consulting firm (Ron Silver & Associates) and maintains his law practice in Miami Beach, Florida.
Senator Silver along with advisory board member Dr. Johnny Mack have been tasked with supporting the Company’s efforts in broadening the acceptance of CBD’s medicinal benefits into a broad range of applications including pain relief and wellness programs.
Senator Silver states, “The opioid crisis is out of control in this country and around the world and if we have an opportunity to improve the quality of life for people in a noninvasive, non-addictive manner we have a moral obligation to do it.” Further Senator Silver adds, “The passage of the 2018 Farm Bill opens up a full range of approval and opportunity for expansion of the Canbiola mission and I am pleased to be on the team.”
According to Canbiola’s CEO Marco Alfonsi, "Having Senator Silver, with his legislative background and contacts, could not be more timely with the recent passage of the 2018 Farm Bill.” Mr. Alfonsi added, "Adding Senator Silver to the Corporate Advisory Board gives us a dimension of accessibility and understanding of the regulatory and governmental processes to help the Company succeed and grow to its full potential.”
Canbiola is a manufacturer of proprietary non-psychoactive cannabinoid products, CBD, extracted from the hemp plant. We are focused on the commercial development of hemp and CBD-based products for both the medical and consumer market. Our product line includes hemp oil drops (of various concentrations), muscle and joint salves, and production of its new CBD CryoGel pain relief product. All products are non-opioid-based, all natural and organic compound products that contain 99.9% pure CBD and are THC free.
Canbiola, Inc. is a public company trading under symbol CANB.
Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. The company has already launched several products found at www.canbiola.com.
Canbiola Investor Relations
Phone: (516) 595-9544